POETIG

Phase 2 trial of ponatinib in patients with metastatic and/or unresectable gastrointestinal stromal tumor (GIST) following failure of prior therapy with imatinib (POETIG trial – POnatinib after rEsisTance to Imatinib in GIST)

II

Status: Studie beendet

Zeitraum

2016

2020

Zentren

10

8

Keine Zentren gesucht

Patienten

60

45

14.04.2022

Beteiligte

AIO-Arbeitsgruppen

Identifier

AIO-STS-0115/ass

Kontakt

Leitung

Prof. Dr. med. Sebastian Bauer

Ansprechpartner*in

Prof. Dr. med. Sebastian Bauer
Telefon +49 201 72385011
E-Mail sebastian.bauer@uni-due.de